During this special season, we want to express our gratitude to all who share with us the commitment to animal health and
Diclacare® 2.5 mg/ml is the new oral suspension for lambs and calves based on diclazuril from the Alivira group. Diclacare® 2.5 mg/ml
This October, Alivira inaugurated a new global R&D center in Ankara, Turkey. With the opening of this new research facility, Alivira Turkey

An Alivira Group Company
P. I. La Borda Mas Pujades 11-12
P. I. La Borda, Borges Blanques 21-25
08140 Caldes de Montbui
Barcelona (Spain)
Usar ese formulario solo para consultas de Farmacovigilancia.
Por favor, no usarlo para otros temas.
The Alivira Spain newsletter